Filing Flows › Enovis (ENOV) › R&D spending
Enovis (ENOV) R&D spending by quarter
Enovis' R&D spending was $31.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 7 quarters it ranged from $28.5M (Q1 2025) to $31.7M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $31.3M | -1% | +5% |
| Q2 2026 | $31.7M | +0.5% | +3% |
| Q1 2026 | $31.5M | +0.5% | +11% |
| Q4 2025 | $31.4M | +5% | — |
| Q3 2025 | $29.7M | -3% | — |
| Q2 2025 | $30.7M | +8% | — |
| Q1 2025 | $28.5M | — | — |
Q3 2026 at a glance
Enovis, Q3 2026: revenue $559M (+2% year over year), operating margin 0.6%, net earnings $3.4M, operating cash flow $71.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Enovis' R&D spending?
Enovis' R&D spending was $31.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Enovis' R&D spending changed?
Over the last 7 quarters it ranged from $28.5M (Q1 2025) to $31.7M (Q2 2026).